EcoDrugPlus

Ephrin Type-B Receptor 3-Like

Ensembl ID : ENSCMIG00000001417
Gene Symbol: LOC103174293
3 Cross references
172 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSCMIG00000019371
Gene Symbol: EGFR
3 Cross references
287 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSCMIG00000008177
Gene Symbol: ERBB2
3 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSCMIG00000006234
Gene Symbol: ERBB3
3 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSCMIG00000014584
Gene Symbol: ERBB4
4 Cross references
323 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSCMIG00000006851
Gene Symbol: ESR1
4 Cross references
215 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSCMIG00000017751
Gene Symbol: ESRRG
4 Cross references
202 Possible Orthologues:

Exportin 1

Ensembl ID : ENSCMIG00000012980
Gene Symbol: XPO1
4 Cross references
149 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSCMIG00000000072
Gene Symbol: FDFT1
3 Cross references
219 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSCMIG00000000058
Gene Symbol: FNTA
3 Cross references
222 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSCMIG00000009461
Gene Symbol: FGF2
3 Cross references
122 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-Like

Ensembl ID : ENSCMIG00000005123
Gene Symbol: LOC103172519
3 Cross references
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).